TECHNOLOGY

SCARRING
- A GLOBAL UNMET NEED

I'm a paragraph. Click here to add your own text and edit me. It's easy.

THE PROBLEM

Severe ("hypertrophic")  dermal scars can be a stigma,

a burden or even a physical handicap

with reduced mobility of joints.

Severe dermal scars are also reported

after surgery in up to one third of Caucasians and

two thirds of Chinese and Polynesians. 

 

Other indications: 

Scarring and adhesions in body cavities after 

  •  hip or knee replacement

  • back surgery (spinal laminctomy)

  • abdominal surgery

  • gynecological surgery

OUR INNOVATION

Cellastra is pioneering a potentially revolutionary treatment:  CELLEXA

  • A gene vector delivering the genetic code to the wound area

  • to enable robust continuous production of an antiscarring peptide

  • to promote scar less wound healing.

388 Market St #1300, San Francisco, CA 94111, USA

©2018 by Cellastra Inc. Proudly created with Wix.com